"42385-929-18" National Drug Code (NDC)

Efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate 180 TABLET, FILM COATED in 1 BOTTLE (42385-929-18)
(Laurus Labs Limited)

NDC Code42385-929-18
Package Description180 TABLET, FILM COATED in 1 BOTTLE (42385-929-18)
Product NDC42385-929
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameEfavirenz, Lamivudine And Tenofovir Disoproxil Fumarate
Non-Proprietary NameEfavirenz, Lamivudine And Tenofovir Disoproxil Fumarate
Dosage FormTABLET, FILM COATED
UsageORAL
Start Marketing Date20200514
Marketing Category NameANDA
Application NumberANDA213038
ManufacturerLaurus Labs Limited
Substance NameEFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Strength400; 300; 300
Strength Unitmg/1; mg/1; mg/1
Pharmacy ClassesCytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/42385-929-18